Form 4: RxSight Director William Link Granted Over 10,000 Restricted Stock Units

RxSight, Inc. Director William J. Link, Ph.D., was granted 10,752 restricted stock units (RSUs) on June 3, 2025, as part of his compensation, aligning his interests with shareholders.

Summary

• Dr. William J. Link, a Director of RxSight, Inc. (RXST), was granted 10,752 restricted stock units (RSUs) on June 3, 2025.
• Each RSU represents a contingent right to receive one share of RxSight, Inc. Common Stock.
• The RSUs are subject to vesting, with 100% vesting on the earlier of the one-year anniversary of the grant date (June 3, 2025) or the date immediately prior to the next annual meeting of stockholders following the grant date, provided Dr. Link continues as an Outside Director.
• Following this transaction, Dr. Link directly beneficially owns 37,855 shares of Common Stock.
• Additionally, 21,248 shares of Common Stock are indirectly beneficially owned through Link Family Enterprise, L.P., where Dr. Link is a managing partner and may be deemed to share voting and investment power, though he disclaims beneficial ownership except for his pecuniary interest.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a director is generally viewed positively as it aligns the director's financial interests with the long-term performance of the company and its shareholders. While it represents potential future dilution, it is a standard component of director compensation.

Positives

• The grant of 10,752 restricted stock units (RSUs) to Director William J. Link aligns his interests with those of shareholders, as the value of his compensation is tied to the company's stock performance.
• The vesting schedule encourages long-term commitment from the director, as the RSUs vest over approximately one year, contingent on his continued service.

Negatives

• The issuance of 10,752 restricted stock units (RSUs) represents a potential future dilution of existing shareholders' equity upon vesting and conversion into common stock.

Risks

• The vesting of the granted restricted stock units (RSUs) is contingent on Dr. William J. Link's continued service as an Outside Director, meaning the shares would not be received if his directorship ceases before vesting conditions are met.

Future Outlook

NA

Industry Context

NA

Corporate Governance

Related Party Transactions

• Grant of 10,752 restricted stock units (RSUs) to William J. Link, Ph.D., a Director of RxSight, Inc.
• Indirect beneficial ownership of 21,248 shares by Link Family Enterprise, L.P., where William J. Link, Ph.D. is a managing partner.

Stakeholder Impact

• Shareholders: Potential minor dilution from the vesting of RSUs, but improved alignment of director interests with long-term shareholder value.

Next Steps

• Vesting of the 10,752 restricted stock units (RSUs) on the earlier of June 3, 2026 (one-year anniversary of grant) or the date immediately prior to the next annual meeting of stockholders following the grant date, contingent on continued service.

Key Dates

Keywords

RxSight, RXST, Form 4, insider transaction, restricted stock units, RSUs, director compensation, equity grant, beneficial ownership, corporate governance, stock award